Date: 23.3.2012
Researchers found that Crohn's patients who took supplementary CLA showed noticeable improvement. "In our recent open label study of CLA as a supplement in study subjects with mild to moderate CD there was a marked improvement in disease activity and quality of life in 50% of the subjects. CLA was well tolerated by all of the study subjects. These findings are very encouraging and will need to be verified in a randomized controlled trial," said Professor Kim L. Isaacs, a Professor of Gastroenterology at the University of North Carolina at Chapel Hill.
http://www.sciencedaily.com/releases/2012/03/120319194215.htm
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
CVUT - Czech Technical University
Biotechnology Journals - Plant, environmetal, animal biotechnology journals
Traces of DNA in the stomachs of predatory snails provide new insights into the ecology of placozoans
Centipedes used in traditional Chinese medicine offer leads for kidney treatment